SFG
PFE icon

SNS Financial Group’s Pfizer PFE Stock Holding History

SNS Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-64,610
Closed -$2M – 212
2020
Q1 		$2M Sell
64,610
-3,584
-5% -$122K 0.38% 51
2019
Q4 		$2.54M Sell
68,194
-527
-0.8% -$18.8K 0.45% 42
2019
Q3 		$2.34M Buy
+68,721
New +$2.5M 0.45% 46
2017
Q2 		– Sell
-527
Closed -$17K – 196
2017
Q1 		$17K Buy
+527
New +$16.6K ﹤0.01% 198

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SNS Financial Group's PFE Position: Q2 2026 in Review

SNS Financial Group increased its Pfizer (PFE) stake by 1,219% in Q2 2026, buying an estimated $4.04M and bringing the position to 167,096 shares worth $4.02M. The position accounts for 0.08% of the portfolio, ranked #157.

SNS Financial Group first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $6.87M in Q4 2016. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • SNS Financial Group held 167,096 shares of Pfizer worth $4.02M as of Q2 2026.
  • SNS Financial Group bought 154,431 Pfizer shares in Q2 2026, an estimated $4.04M.
  • Pfizer made up 0.08% of SNS Financial Group's portfolio in Q2 2026, its #157 holding.
  • SNS Financial Group first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
  • SNS Financial Group's Pfizer position peaked at $6.87M in Q4 2016.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on SNS Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.